Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease: correction - Bönig, Halvard; Verbeek, Mareike; Herhaus, Peter; Braitsch, Krischan; Beutel, Gernot; Schmid, Christoph; Müller, Nadine Zoé; Bug, Gesine; Döring, Michaela; von Stackelberg, Arend; Tischer, Johanna; Ayuk, Francis; et al. (Journal of translational medicine, 2024)
Gesehen am 01.10.2024